Product Information

METHYLPREDNISOLONE 8 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.9149 per EA under NDC 62135076126. Its NADAC has been published 30 times since Jan 28, 2026.

FDA first approved this application on Feb 22, 2019.

METHYLPREDNISOLONE 8 MG TABLET

Methylprednisolone
$0.9149per EA

Strength

8 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135076126

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

METHYLPREDNISOLONE

Approval Type

Generic (ANDA)

FDA Application

ANDA209097

FDA Approved

2/22/2019

On Market Since

2/22/2019

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for METHYLPREDNISOLONE 8 MG TABLET has been published 30 times since Jan 28, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.9149 per EA
All-time high$1.0323 (Jun 10, 2026)
All-time low$0.9149 (Aug 19, 2026)
52-week high$1.0323
52-week low$0.9149
Median price$0.9893
Average price$0.9885
Largest weekly change-5.4% (Jul 22, 2026)
Weeks tracked30
Tracking sinceJan 28, 2026

Price History

1W

-5.1%

1M

-5.1%

3M

-11.4%

6M

-5.3%

1Y

N/A

3Y

N/A

5Y

N/A

All

-0.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of METHYLPREDNISOLONE 8 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPREDNISOLONE 8 MG TABLET, manufactured by Chartwell RX LLC, is $0.9149 per EA (NDC 62135076126), effective Aug 19, 2026.

How has the price of METHYLPREDNISOLONE 8 MG TABLET changed over time?

Over the history we have for it, the NADAC for METHYLPREDNISOLONE 8 MG TABLET has held within roughly two percent of its current level. It has been tracked across 30 weekly CMS publications since Jan 28, 2026.

What are the highest and lowest recorded NADAC prices for METHYLPREDNISOLONE 8 MG TABLET?

Since Jan 28, 2026, the NADAC for METHYLPREDNISOLONE 8 MG TABLET has ranged from a low of $0.9149 (Aug 19, 2026) to a high of $1.0323 (Jun 10, 2026), with a median of $0.9893 per EA.

Are there cheaper alternatives to METHYLPREDNISOLONE 8 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as METHYLPREDNISOLONE 8 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures METHYLPREDNISOLONE 8 MG TABLET?

METHYLPREDNISOLONE 8 MG TABLET (NDC 62135076126) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.